Log In
BCIQ
Print this Print this
 

Activin receptor-like kinase 2 (ALK2) (ACVR1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Activin receptor-like kinase 2 (ALK2) (ACVR1)

BCIQ
Print ChartPrint this
Phase of DevelopmentPreclinical
Hematology

1




 Products Targeting Activin receptor-like kinase 2 (ALK2) (ACVR1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$780.0M

$200.0M

$580.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2016

$780.0M

$200.0M

$580.0M

Get a free BioCentury Trial today